Anila Lingamneni - Sep 11, 2023 Form 4 Insider Report for HAEMONETICS CORP (HAE)

Role
EVP, Chief Technology Officer
Signature
/s/ Thomas V. Powers, attorney-in-fact for Ms. Lingamneni
Stock symbol
HAE
Transactions as of
Sep 11, 2023
Transactions value $
-$207,450
Form type
4
Date filed
9/13/2023, 04:20 PM
Previous filing
Jun 1, 2023
Next filing
Apr 17, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HAE Common Stock Sale -$207K -2.31K -13.72% $90.00 14.5K Sep 11, 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Transaction pursuant to an existing 10b5-1 trading plan dated June 2, 2023 (fully executed as of June 5, 2023).
F2 This number includes unvested restricted stock units previously reported.